Enovis Corporation is a medical technology company dedicated to developing clinically differentiated solutions through the manufacturing and distribution of medical devices for reconstructive surgery, rehabilitation, pain management, and physical therapy. It operates in two segments: Prevention & Recovery, which offers rigid bracing products, orthopedic soft goods, vascular systems, compression garments, and recovery sciences products like bone growth and electrical stimulators; and Reconstructive, which focuses on knee, hip, shoulder, elbow, foot, ankle, and finger implants, along with surgical tools and minimally invasive surgery solutions through Novastep. The ENOV average annual return 10 years is shown above.
The Average Annual Return on the ENOV average annual return 10 years page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether ENOV average annual return 10 years or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the ENOV average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|
Free ENOV Email Alerts:
Video: Don't Forget Dividends in Average Annual Return!
